Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON52187Phase 4Recruiting
Phase 4, randomised, open-label trial in opioid use disorder (OUD) and chronic pain comparing Suboxone arm with Methadone arm (2 arms). Primary endpoint: Current Opioid Misuse Measure score at 2 months. Started May 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON52187.